BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6342879)

  • 1. Lymphocyte migration in malignant disease.
    Crowther D; Wagstaff J
    Clin Exp Immunol; 1983 Mar; 51(3):413-20. PubMed ID: 6342879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
    Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
    Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumor growth on migratory properties of T lymphocytes in rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1980; 27(6):675-82. PubMed ID: 6973097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition.
    Stevens SK; Weissman IL; Butcher EC
    J Immunol; 1982 Feb; 128(2):844-51. PubMed ID: 6976385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].
    Michlmayr G; Huber C; Fink U; Falkensammer M; Huber H
    Schweiz Med Wochenschr; 1974 Jun; 104(23):815-20. PubMed ID: 4546217
    [No Abstract]   [Full Text] [Related]  

  • 7. Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.
    de Sousa M; Smithyman A; Tan C
    Am J Pathol; 1978 Feb; 90(2):497-520. PubMed ID: 304676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization of lymphocytes migrating through chronically inflamed tissues.
    Issekutz TB; Chin W; Hay JB
    Immunology; 1982 May; 46(1):59-66. PubMed ID: 6978844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma cutis of apparent B cell origin.
    Goldberg J; Davey FR; Lowenstein F; Gottlieb AJ
    Arch Pathol Lab Med; 1978 Jan; 102(1):15-8. PubMed ID: 304342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin malignant lymphomas of B-cell lineage with special reference to their lymph node involvement pattern.
    Syrjänen KJ
    Arch Geschwulstforsch; 1980; 50(1):66-71. PubMed ID: 6969583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological characteristics of malignant skin lymphomas].
    Shaposhnikov OK; Rodionov AN
    Vestn Dermatol Venerol; 1982 Mar; (3):4-11. PubMed ID: 6978580
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 14. [Classification and prognosis of malignant non-Hodgkin lymphomas].
    Krüger G
    MMW Munch Med Wochenschr; 1980 Oct; 122(44):1527-33. PubMed ID: 6779109
    [No Abstract]   [Full Text] [Related]  

  • 15. [Distribution of T and B lymphocytes in peripheral blood in various forms of cutaneous lymphomas].
    Carapeto FJ
    Actas Dermosifiliogr; 1978; 69(1-2):1-10. PubMed ID: 311988
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pathophysiology of malignant lymphoma from the hematological point of view. 3. Changes in peripheral blood lymphocyte count and the recovery of cell-mediated immune function after therapy of T-, B-malignant lymphomas and Hodgkin's disease].
    Kinoshita K; Amagasaki T; Momita S; Ikeda S; Ichimaru M; Kamihira S
    Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1068-80. PubMed ID: 3788434
    [No Abstract]   [Full Text] [Related]  

  • 17. Abundant expression of chemokines in malignant and infective human lymphadenopathies.
    Tedla N; Palladinetti P; Wakefield D; Lloyd A
    Cytokine; 1999 Jul; 11(7):531-40. PubMed ID: 10419655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative migration of T- and B-lymphocyte subpopulations into skin inflammatory sites.
    van Dinther-Janssen AC; van Maarsseveen AC; de Groot J; Scheper RJ
    Immunology; 1983 Mar; 48(3):519-27. PubMed ID: 6600705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern classifications of non-Hodgkin lymphomas].
    Iakovleva IA; Korchmaru IF
    Vopr Onkol; 1986; 32(6):3-17. PubMed ID: 3523992
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution of normal T lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E
    Neoplasma; 1982; 29(6):727-34. PubMed ID: 6984490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.